drugset / Trial / NCT01009853
Steady State Study of Codeine Sulfate
NaSingle-groupOpen-labelTreatment
Summary
Study to characterize the steady-state pharmacokinetics of codeine and its metabolites morphine, morphine-3-glucuronide (M3G), and morphine-6-glucuronide (M6G) after oral administration of Roxane Laboratories' codeine sulfate tablets administered at a dose of 15 mg Q4H x 5 days.
Timeline
- Start
- 2008-01
- Primary completion
- 2008-01
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Codeine | Small molecule | 15 mg | Oral |
Indications
No indication recorded.